A recent study highlights the effectiveness of Pain Coping Skills Training (PCST) in reducing chronic pain among dialysis patients. The study, involving 643 participants, shows how non-opioid ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...
Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Learn more about whether Enovis Corporation or ICU Medical, Inc. is a better investment based on AAII's A+ Investor grades, ...
In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback